Crohn's Disease Clinical Trials in Westlake, Ohio

6 studies are recruiting for crohn's disease in Westlake, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

    Crohn's disease (CD) and Ulcerative colitis (UC) are 2 types of inflammatory bowel diseases which cause long-lasting, severe inflammation (redness, swelling) in the digestive tract. CD can affect any part of the digestive tract causing many different symptoms including belly pain, diarrhea, tiredne…

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Gastro Intestinal Research Institute of Northern Ohio /ID# 283860, Westlake, Ohio
    Locations
    36 in total
    Run by
    AbbVie

    See if you can join NCT07697456 on ClinicalTrials.gov

  2. A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

    Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this study is to check for how many participants with UC and CD signs and symptoms disappear after 3.5 month…

    Stage
    Phase 4
    Ages
    18 to 80
    Site
    NorthShore Gastroenterology Research, LLC, Westlake, Ohio
    Locations
    101 in total
    Run by
    Takeda

    See if you can join NCT06581328 on ClinicalTrials.gov

  3. A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

    The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with adalimumab or vedolizumab (VDZ) together with ustekinumab (UST) in adults with moderate to severe Crohn's Disease, and the effect of treatment with vedolizumab alone, after the dual …

    Stage
    Phase 4
    Ages
    18 to 70
    Site
    Gastro Intestinal Research Institute of Northern Ohio, LLC., Westlake, Ohio
    Locations
    48 in total
    Run by
    Takeda

    See if you can join NCT06045754 on ClinicalTrials.gov

  4. Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

    The main purpose of this study is to evaluate the efficacy and safety of mirikizumab and placebo compared with mirikizumab and concomitantly administered tirzepatide in adult participants with moderately to severely active CD and obesity, or overweight. The maximum duration of this study is up to 6…

    Stage
    Phase 3
    Ages
    18 to 70
    Site
    Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake, Ohio
    Locations
    183 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT06937099 on ClinicalTrials.gov

  5. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study, comprised of 3 sub-studies, to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active CD. Study details include: The study duration may be up to 35 …

    Stage
    Phase 3
    Ages
    16 to 80
    Site
    North Shore Gastroenterology Research - Site Number: 8400130, Westlake, Ohio
    Locations
    301 in total
    Run by
    Sanofi

    See if you can join NCT07184931 on ClinicalTrials.gov

  6. A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    This is a multicenter, randomized, double-blind, placebo-controlled, maintenance, Phase 3 study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn's Disease (CD). Study details include: The study duration may be up to 286 weeks including: * 40-…

    Stage
    Phase 3
    Ages
    16 to 80
    Site
    North Shore Gastroenterology Research-Site Number: 8400130, Westlake, Ohio
    Locations
    35 in total
    Run by
    Sanofi

    See if you can join NCT07184944 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.